Insider Transactions in Q1 2021 at Arcus Biosciences, Inc. (RCUS)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2021
|
Kathryn E Falberg Director |
BUY
Open market or private purchase
|
Indirect |
20,000
+16.38%
|
$560,000
$28.35 P/Share
|
|
Mar 16
2021
|
Jennifer Jarrett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
8,661
-6.89%
|
$303,135
$35.03 P/Share
|
|
Mar 16
2021
|
William Grossman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,127
-16.39%
|
$74,445
$35.03 P/Share
|
|
Feb 01
2021
|
Terry J Rosen Chief Executive Officer |
SELL
Bona fide gift
|
Indirect |
311,900
-100.0%
|
-
|
|
Jan 31
2021
|
Gilead Sciences Inc > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
5,650,000
+28.88%
|
$220,350,000
$39.0 P/Share
|
|
Jan 19
2021
|
Ii Robert C. Goeltz Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+41.67%
|
-
|
|
Jan 19
2021
|
William Grossman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,750
+42.39%
|
-
|
|
Jan 19
2021
|
Juan C. Jaen President |
BUY
Grant, award, or other acquisition
|
Direct |
19,375
+8.49%
|
-
|
|
Jan 19
2021
|
Jennifer Jarrett Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
400,000
+44.41%
|
-
|
|
Jan 19
2021
|
Terry J Rosen Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+16.11%
|
-
|
|
Jan 19
2021
|
Carolyn C. Tang General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
12,538
+38.67%
|
-
|